Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy-Reference-Cited by-同舟云学术

Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy

Published:2024-05 Issue: Volume:271 Page:116409
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Waiker Digambar Kumar,Verma Akash,Gajendra T.A.,Namrata ,Roy Anima,Kumar Pradeep,Trigun Surendra Kumar,Srikrishna Saripella,Krishnamurthy Sairam,Davisson Vincent Jo,Shrivastava Sushant Kumar^ORCID

Funder

Indian Institute of Technology (BHU) Varanasi

Science and Engineering Research Board

Publisher

Elsevier BV

Reference77 articles.

1. Alzheimer's disease facts and figures;Association;Alzheimer's Dementia,2019

2. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein;Ahsan;Sci. Rep.,2015

3. Cholinesterase inhibitors for Alzheimer's disease;Birks;Cochrane Database Syst. Rev.,1996

4. Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research;Monroe;J. Geriatr. Psychiatr. Neurol.,2012

5. Efficacy of antidepressants for depression in Alzheimer's disease: systematic review and meta-analysis;Orgeta;J. Alzheim. Dis.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current pharmacophore based approaches for the development of new anti-Alzheimer’s agents;Bioorganic & Medicinal Chemistry;2024-09